TY - JOUR
T1 - Correction to
T2 - The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart (Cardiovascular Drugs and Therapy, (2019), 33, 6, (669-674), 10.1007/s10557-019-06914-9)
AU - Tate, Mitchel
AU - Higgins, Gavin C.
AU - De Blasio, Miles J.
AU - Lindblom, Runa
AU - Prakoso, Darnel
AU - Deo, Minh
AU - Kiriazis, Helen
AU - Park, Min
AU - Baeza-Garza, Carlos D.
AU - Caldwell, Stuart T.
AU - Hartley, Richard C.
AU - Krieg, Thomas
AU - Murphy, Michael P.
AU - Coughlan, Melinda T.
AU - Ritchie, Rebecca H.
PY - 2020/4/1
Y1 - 2020/4/1
N2 - The article “The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart” written by Mitchel Tate, Gavin C. Higgins, Miles J. De Blasio, Runa Lindblom, Darnel Prakoso, Minh Deo, Helen Kiriazis, Min Park, Carlos D. Baeza-Garza, Stuart T. Caldwell, Richard C. Hartley, Thomas Krieg, Michael P. Murphy, Melinda T. Coughlan, and Rebecca H. Ritchie was originally published Online First without Open Access. After publication, the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2019 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The original article has been corrected.
AB - The article “The Mitochondria-Targeted Methylglyoxal Sequestering Compound, MitoGamide, Is Cardioprotective in the Diabetic Heart” written by Mitchel Tate, Gavin C. Higgins, Miles J. De Blasio, Runa Lindblom, Darnel Prakoso, Minh Deo, Helen Kiriazis, Min Park, Carlos D. Baeza-Garza, Stuart T. Caldwell, Richard C. Hartley, Thomas Krieg, Michael P. Murphy, Melinda T. Coughlan, and Rebecca H. Ritchie was originally published Online First without Open Access. After publication, the author decided to opt for Open Choice and to make the article an Open Access publication. Therefore, the copyright of the article has been changed to © The Author(s) 2019 and the article is forthwith distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits use, duplication, adaptation, distribution, and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The original article has been corrected.
UR - http://www.scopus.com/inward/record.url?scp=85079715301&partnerID=8YFLogxK
U2 - 10.1007/s10557-019-06929-2
DO - 10.1007/s10557-019-06929-2
M3 - Comment / Debate
C2 - 32062792
AN - SCOPUS:85079715301
SN - 0920-3206
VL - 34
SP - 223
JO - Cardiovascular Drugs and Therapy
JF - Cardiovascular Drugs and Therapy
IS - 2
ER -